The90's $299 Gem pendant syncs a UVA/UVB sensor to a personalized skin type app. The launch coverage did not include an independent dermatologist, and that absence is the story.
The UV index has been a tap away on your phone's weather app for years. So why would anyone pay $299 for a necklace that promises to tell them the same thing, only from a sensor on your collarbone?
That is the question worth asking about The90 Gem, the pendant The90 launched this week and CNET's product coverage describes as a real-time UVA-and-UVB reader that syncs to a phone app and a personalized skin-type profile. Founder Stacy Salvi, whom the company says previously led the acquisition of Fitbit by Google, frames the product as a reordering of how sunscreen gets used: not a one-time morning ritual but, in her words as quoted by CNET, "an adaptive, responsive system built around your actual UV load."
The pitch lands at a moment when personal UV data is showing up in more places, from phone weather apps to cosmetics-company skin patches. The90 is pitching the Gem as the most wearable, most personal version of that trend. None of that prior context is referenced in the launch coverage, and the CNET piece did not include an independent dermatologist, dermatology-society statement, or peer-reviewed input on the Gem's sensor accuracy or on the broader limits of consumer UV wearables.
That absence matters because the load-bearing claim here is behavioral. The Gem tracks exposure, sends reapplication reminders, and tailors guidelines to skin type. The published evidence that personal UV data moves sun-protective behavior, rather than adding another screen to glance at, is thin. Standard dermatology guidance still anchors on SPF reapplication every two hours, and on shade, hats, or clothing. A wearable that confirms the weather app is right does not, on its own, change that calculus.
The marketing is doing real work, too. The90's first design targets women, with the company telling CNET that women are "most familiar with UV risk" and that the roadmap is men and children later. That is a brand assertion, not a research finding, and the gender framing deserves scrutiny. The device is priced and positioned as women's wellness hardware, and the $199 "exclusive" deal is routed through a single investor's community, Lauryn Bosstick's Skinny Confidential. Whether the "designed with women in mind" pitch reflects a deliberate product choice, a go-to-market bet, or a marketing shortcut cannot be answered from the launch coverage.
What a reader can take from the launch: the product exists, retail is $299, the app is the actual product, and the founder's wearable pedigree is a company-issued claim rather than an independent credential. What the launch does not answer is whether the device changes behavior, whether its sensor matches medical-grade UV meters, and whether the women-first positioning is a clinical decision or a commercial one.
The next signal worth watching is independent testing. If a board-certified dermatologist or a public-health researcher weighs in on the Gem's accuracy and on the behavior-change case, the category question gets sharper. Until then, the pendant sits in a familiar spot for consumer wearables: well-marketed, plausibly useful, and still waiting for evidence that it does what the launch copy says it does.